Rationale behind high-dose amoxicillin therapy for acute otitis media due to penicillin-nonsusceptible pneumococci: Support from in vitro pharmacodynamic studies

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 9, 1997, Pages 1926-1932

  Lister, Philip D ^a   Pong, Alice ^a   Chartrand, Stephen A ^a   Sanders, Christine C ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFPODOXIME; CEFPROZIL; CEFTRIAXONE; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN G;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ARTICLE; DOSE RESPONSE; DRUG EFFICACY; DRUG ELIMINATION; DRUG MEGADOSE; HUMAN; OTITIS MEDIA; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0030853543     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.9.1926     Document Type: Article

References (33)

1. Andes, D., A. Urban, and W. A. Craig. 1995. In-vivo activity of amoxicillin (AMOX) and amoxicillin/clavulanate (AMOX/CLAV) against penicillin-resistant pneumococci, abstr. A82, p. 16. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
2. Blaser, J., B. B. Stone, and S. H. Zinner. 1985. Two compartment kinetic model with multiple artificial capillary units. J. Antimicrob. Chemother. 15(Suppl. A):131-137.
3. Block, S. L., C. J. Harrison, J. A. Hedrick, R. D. Tyler, R. A. Smith, E. Keegan, and S. A. Chartrand. 1995. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr. Infect. Dis. J. 15:751-759.
4. Boken, D. J., S. A Chartrand, E. Smith-Moland, and R. V. Goering. 1996. Colonization with penicillin-nonsusceptible Streptococcus pneumoniae in urban and rural child-care centers. Pediatr. Infect. Dis. J. 15:667-672.
5. Burch, D. Personal communication. Smith-Kline Beecham Investigators Meeting, November 1996.
6. Canafax, D. M., N. Nonomura, G. R. Erdmann, C. T. Le, S. K. Juhn, and G. S. Giebink. 1989. Experimental animal models for studying antimicrobial pharmacokinetics in otitis media. Pharmaceut. Res. 6:279-285.
7. Cars, O., and I. Odenholt-Tornqvist. 1993. The post-antibiotic sub-MIC effect in vitro and in vivo. J. Antimicrob. Chemother. 31(Suppl. D):159-166.
8. Craig, W. A., and D. Andes. 1996. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr. Infect. Dis. J. 15:255-259.
9. Craig, W. A., and S. Ebert. 1991. Killing and regrowth of bacteria in vitro: a review. Scand. J. Infect. Dis. 74:S63-S70.
10. Daikos, G. L., G. G. Jackson, V. T. Lolans, and D. M. Livermore. 1990. Adaptive resistance to aminoglycoside antibiotics from first-exposure downregulation. J. Infect. Dis. 162:414-420.
11. Daikos, G. L., V. T. Lolans, and G. G. Jackson. 1991. First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use. Antimicrob. Agents Chemother. 35:117-123.
12. Doern, G. V., A. Brueggemann, H. P. Holley, Jr., and A. M. Rauch. 1996. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob. Agents Chemother. 40:1208-1213.
13. Erdmann, G. R., J. C. Steury, C. T. Le, S. K. Juhn, G. S. Giebink, and D. M. Canafax. 1993. Effects of pH and protein binding on middle ear antimicrobial drug penetration may explain acute otitis media treatment failures, p. 446-449. In D. J. Lim, C. D. Bluestone, J. O. Klein, J. D. Nelson, and P. L. Ogra (ed.), Recent advances in otitis media. Decker Periodicals, New York, N.Y.
14. Garcia-Bustos, J. F., B. T. Chait, and A. Tomasz. 1988. Altered peptidoglycan structure in a pneumococcal transformant resistant to penicillin. J. Bacteriol. 170:2143-2147.
15. Gilleland, L. B., H. E. Gilleland, J. A. Gibson, and F. R. Champlin. 1989. Adaptive resistance to aminoglycoside antibiotics in Pseudomonas aeruginosa. J. Med. Microbiol. 29:41-50.
16. Klein, J. O. 1995. Otitis externa, otitis media, mastoiditis, p. 579-585. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practices of infectious diseases. Churchill Livingstone, New York, N.Y.
17. Krause, P. J., N. J. Owens, C. H. Nightingale, J. J. Klimek, W. B. Lehmann, and R. Quintiliani. 1982. Penetration of amoxicillin, cefaclor, erythromycin-sulfisoxazole, and trimethroprim-sulfamethoxazole into the middle ear fluid of patients with chronic serous otitis media. J. Infect. Dis. 145:815-821.
18. Lister, P. D. 1995. Multiply-resistant pneumococcus: therapeutic problems in the management of serious infections. Eur. J. Clin. Microbiol. Infect. Dis. 14(Suppl. 1):18-25.
19. Lister, P. D., and C. C. Sanders. 1997. Unpublished data.
20. Marshall, K. J., D. M. Musher, D. Watson, and E. O. Mason, Jr. 1993. Testing of Streptococcus pneumoniae for resistance to penicillin. J. Clin. Microbiol. 31:1246-1250.
21. McCracken, G. H. Personal communication, May 1996.
22. McGrath, B. J., E. M. Bailey, K. C. Lamp, and M. J. Rybak. 1992. Pharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection model. Antimicrob. Agents Chemother. 36:2741-2746.
23. Medical Economics Data. 1996. Physicians' desk reference. Medical Economics Data, Montvale, N.J.
24. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
25. Nelson, C. T., E. O. Mason, Jr., and S. L. Kaplan. 1994. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatr. Infect. Dis. J. 13:585-589.
26. Odenholt-Tornqvist, I., E. Löwdin, and O. Cars. 1991. Pharmacodynamic effects of subinhibitory concentrations of β-lactam antibiotics in vitro. Antimicrob. Agents Chemother. 35:1834-1839.
27. Sande, M. A., O. M. Korzeniowski, G. M. Allegro, R. O. Brennan, O. Zak, and W. M. Scheld. 1981. Intermittent or continuous therapy of experimental meningitis due to Streptococcus pneumoniae in rabbits: preliminary observations on the postantibiotic effect in vivo. Rev. Infect. Dis. 3:98-109.
28. Sanders, C. C., and W. E. Sanders, Jr. 1992. β-Lactam resistance in gram-negative bacteria: global trends and clinical impact. Clin. Infect. Dis. 15:824-839.
29. Todd, P. A., and P. Benfield. 1990. Amoxicillin/clavulanic acid: an update of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 39:264-307.
30. Vergeres, P., and J. Blaser. 1992. Amikacin, ceftazidime, and flucloxacillin against suspended and adherent Pseudomonas aeruginosa and Staphylococcus epidermidis in an in vitro model of infection. J. Infect. Dis. 165:281-289.
31. Vogelman, B., S. Gudmundsson, J. Leggett, S. Ebert, and W. A. Craig. 1988. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in animal models. J. Infect. Dis. 158:831-847.
32. Wald, E. R., D. D. Rohn, D. M. Chiponis, M. M. Blatter, K. S. Reisinger, and F. P. Wucher. 1983. Quantitative cultures of middle-ear fluid in acute otitis media. J. Pediatr. 102:259-261.
33. Zighelboim, S., and A. Tomasz. 1980. Penicillin-binding proteins of multiply antibiotic-resistant South African strains of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 17:434-442.